SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

The Metals Company (TMC) is commanding significant investor attention following key U.S. regulatory updates, including NOAA's finalized rule to streamline deep-sea mining permits and strong White House backing for expediting this critical sector. Community discussions are centered on an upcoming Congressional hearing featuring TMC's CEO, with many anticipating a major breakout driven by increased government alignment and the strategic importance of securing critical minerals.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing an extraordinary rally, driven by analyst upgrades and an anticipated, prolonged shortage in AI-driven memory and storage, with products reportedly sold out well into 2026. The community is sharply split, with many celebrating significant gains and its status as a market leader, while others warn of an overheated, unsustainable "bubble" and imminent correction.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following substantial insider share purchases by its CEO, which is fueling intense community discussion about the stock's future trajectory. Investors are eagerly anticipating potential catalysts and debating the implications for short positions, despite mixed reactions to recent price movements.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Advanced Micro Devices (AMD) is a top trending stock, with discussions centering on reports of a CPU supply shortage that is seen as redirecting demand toward the company and potentially impacting competitors. The community is sharply divided between those who believe it's a strong growth play benefiting from exploding AI compute demand and those cautioning about an overextended valuation following its significant market performance.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is experiencing significant bullish momentum ahead of its upcoming earnings report, driven by analyst upgrades and growing confidence in its strategic turnaround and advanced manufacturing processes. The community is actively discussing the potential for major government contracts and a sustained rally, with many anticipating a significant short squeeze, though some express caution about a 'sell the news' event.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending with strong bullish sentiment after securing a key arbitration win against Repsol, which is easing investor concerns about ongoing legal disputes. This, coupled with its Plaquemines facility ramping up production significantly and benefiting from widening natural gas price spreads in Europe due to a cold snap, is sparking discussions of a potential short squeeze and its long-term growth as a major global LNG exporter.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle (ORCL) is trending as community discussion intensifies around a potential TikTok deal closure, which many anticipate will lead to a significant short squeeze and price rally. Conversely, substantial concern persists regarding the company's mounting debt from AI infrastructure investments and criticisms of management, fueling sharp volatility and a debate over Oracle's long-term cloud strategy versus immediate financial pressures.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending as market sentiment responds to news of a 'Greenland deal framework' with NATO and the withdrawal of previously threatened EU tariffs. This rapid de-escalation of geopolitical tensions is a major talking point within the community, with many interpreting it as a predictable market 'TACO trade' that has triggered a broad rally after recent uncertainty.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending due to its recent licensing deal with Pfizer for the Matrix-M adjuvant, a move seen by the community as a significant validation of its platform technology. Traders are keenly observing the high short interest, fueling speculation of a potential short squeeze as this partnership could pave the way for additional collaborations with major pharmaceutical players.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is seeing a significant surge, primarily fueled by encouraging long-term data from its personalized cancer vaccine for melanoma, developed in collaboration with Merck. The positive 5-year follow-up results, demonstrating sustained improvement in recurrence-free survival, are exciting the community who believe this positions the company for substantial future growth beyond its initial vaccine success. Many investors are actively discussing its potential revaluation, arguing it is currently undervalued compared to peers given this therapeutic pipeline expansion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Fate Therapeutics (NASDAQ:FATE) Stock Price Crosses Above 50-Day Moving Average - Here's What Happened

Fate Therapeutics (NASDAQ:FATE) Stock Price Crosses Above 50 Day Moving Average - Should You Sell...

Cindy Tahl Sells 10,589 Shares of Fate Therapeutics (NASDAQ:FATE) Stock

Fate Therapeutics, Inc. (NASDAQ:FATE - Get Free Report) insider Cindy Tahl sold 10,589 shares of the business's stock in a transaction dated Friday, January 9th. The shares were sold at an average...

Insider Selling: Fate Therapeutics (NASDAQ:FATE) Insider Sells 10,589 Shares of Stock

Fate Therapeutics, Inc. (NASDAQ:FATE - Get Free Report) insider Cindy Tahl sold 10,589 shares of the stock in a transaction that occurred on Friday, January 9th. The shares were sold at an average...

Fate Therapeutics, Inc. (NASDAQ:FATE) Receives Consensus Recommendation of "Hold" from Brokerages

Shares of Fate Therapeutics, Inc. (NASDAQ:FATE - Get Free Report) have received a consensus recommendation of "Hold" from the nine ratings firms that are currently covering the firm, Marketbeat...

Fate Therapeutics (NASDAQ:FATE) Shares Pass Below Two Hundred Day Moving Average - Here's Why

Fate Therapeutics (NASDAQ:FATE) Stock Passes Below 200 Day Moving Average - Here's What Happened...

Fate Therapeutics (NASDAQ:FATE) Shares Pass Below Two Hundred Day Moving Average - What's Next?

Fate Therapeutics (NASDAQ:FATE) Shares Cross Below Two Hundred Day Moving Average - Here's Why...

Fate Therapeutics, Inc. (NASDAQ:FATE) Given Consensus Rating of "Hold" by Analysts

Shares of Fate Therapeutics, Inc. (NASDAQ:FATE - Get Free Report) have earned a consensus rating of "Hold" from the nine analysts that are covering the firm, MarketBeat Ratings reports. One equities...

Fate Therapeutics (NASDAQ:FATE) Stock Price Passes Below 200 Day Moving Average - Here's What Happened

Fate Therapeutics (NASDAQ:FATE) Stock Price Passes Below 200 Day Moving Average - What's Next...

Fate Therapeutics, Inc. (NASDAQ:FATE) Given Average Rating of "Hold" by Brokerages

Shares of Fate Therapeutics, Inc. (NASDAQ:FATE - Get Free Report) have been assigned a consensus rating of "Hold" from the nine brokerages that are presently covering the firm, Marketbeat.com...

Fate Therapeutics (NASDAQ:FATE) Announces Quarterly Earnings Results

Fate Therapeutics (NASDAQ:FATE - Get Free Report) posted its earnings results on Thursday. The biopharmaceutical company reported ($0.27) earnings per share for the quarter, topping analysts...

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko, and John D. Mendlein on April 27, 2007 and is headquartered in San Diego, CA.

Fate Therapeutics Inc

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

Current Price	$1.18
Prev Close	$1.10
Open	$1.13
Dividend Yield	0.00%
50-Day Moving Average	$1.05
Beta	1.64
Avg. Volume	1.36M
PE Ratio	-0.83

52-Week High	$1.94
52-Week Low	$0.661
Market Capitalization	$126.89M
EPS (Annual)	-$1.64
Price to Book	0.54
Revenue Per Employee	$75,309.39
Enterprise Value/EBITDA	N/A

FATE
Fate Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FATE News

FATEFate Therapeutics Inc